News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,503 Results
Type
Article (31949)
Company Profile (12)
Press Release (143542)
Multimedia
Podcasts (9)
Webinars (10)
Section
Business (51956)
Career Advice (367)
Deals (3216)
Drug Delivery (11)
Drug Development (23839)
Employer Resources (32)
FDA (3345)
Job Trends (3174)
News (80356)
Policy (4193)
Tag
Academia (2409)
Academic (1)
Accelerated approval (6)
Adcomms (9)
Allergies (35)
Alliances (10854)
ALS (48)
Alzheimer's disease (602)
Antibody-drug conjugate (ADC) (45)
Approvals (3445)
Artificial intelligence (112)
Autoimmune disease (28)
Automation (7)
Bankruptcy (17)
Best Places to Work (2655)
BIOSECURE Act (3)
Biosimilars (13)
Biotechnology (12)
Bladder cancer (36)
Brain cancer (26)
Breast cancer (181)
Cancer (1316)
Cardiovascular disease (90)
Career advice (344)
Career pathing (9)
CAR-T (77)
CDC (19)
Cell therapy (192)
Cervical cancer (9)
Clinical research (19541)
Collaboration (316)
Company closure (1)
Compensation (23)
Complete response letters (6)
COVID-19 (1198)
CRISPR (28)
C-suite (535)
Cystic fibrosis (32)
Data (2013)
Decentralized trials (1)
Denatured (6)
Depression (36)
Diabetes (121)
Diagnostics (1729)
Digital health (4)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (49)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (6548)
Editorial (8)
Employer branding (2)
Employer resources (30)
Events (18447)
Executive appointments (620)
FDA (3906)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (389)
Gene editing (58)
Generative AI (5)
Gene therapy (132)
GLP-1 (164)
Government (989)
Guidances (24)
Healthcare (5033)
HIV (14)
Huntington's disease (6)
IgA nephropathy (24)
Immunology and inflammation (22)
Immuno-oncology (12)
Indications (19)
Infectious disease (1262)
Inflammatory bowel disease (54)
Inflation Reduction Act (1)
Influenza (36)
Intellectual property (36)
Interviews (41)
IPO (1455)
IRA (8)
Job creations (576)
Job search strategy (319)
JPM (4)
Kidney cancer (7)
Labor market (16)
Layoffs (38)
Leadership (5)
Legal (682)
Liver cancer (26)
Longevity (2)
Lung cancer (149)
Lymphoma (120)
Machine learning (10)
Management (9)
Manufacturing (95)
MASH (59)
Medical device (3113)
Medtech (3123)
Mergers & acquisitions (1850)
Metabolic disorders (250)
Multiple sclerosis (40)
NASH (5)
Neurodegenerative disease (93)
Neuropsychiatric disorders (11)
Neuroscience (921)
Neurotech (1)
NextGen: Class of 2026 (1791)
Non-profit (1712)
Now hiring (6)
Obesity (64)
Opinion (37)
Ovarian cancer (62)
Pain (40)
Pancreatic cancer (71)
Parkinson's disease (84)
Partnered (6)
Patents (69)
Patient recruitment (133)
Peanut (14)
People (33264)
Phase 1 (6171)
Phase 2 (8944)
Phase 3 (5992)
Pipeline (887)
Policy (51)
Postmarket research (956)
Preclinical (3152)
Press Release (25)
Prostate cancer (68)
Psychedelics (10)
Radiopharmaceuticals (75)
Rare diseases (174)
Real estate (1284)
Recruiting (16)
Regulatory (3350)
Reports (4)
Research institute (1379)
Resumes & cover letters (23)
Rett syndrome (4)
RNA editing (3)
RSV (5)
Schizophrenia (29)
Series A (59)
Series B (31)
Sickle cell disease (27)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (1114)
Stomach cancer (1)
Supply chain (1)
Tariffs (7)
The Weekly (3)
Vaccines (277)
Venture capital (12)
Weight loss (37)
Women's health (20)
Worklife (2)
Date
Today (22)
Last 7 days (104)
Last 30 days (394)
Last 365 days (6200)
2026 (556)
2025 (6295)
2024 (7451)
2023 (9210)
2022 (11453)
2021 (13189)
2020 (12725)
2019 (12097)
2018 (8979)
2017 (8678)
2016 (8888)
2015 (10205)
2014 (7787)
2013 (7567)
2012 (7523)
2011 (7536)
2010 (6760)
Location
Africa (265)
Alabama (15)
Alaska (3)
Arizona (53)
Arkansas (6)
Asia (10702)
Australia (2669)
California (2352)
Canada (668)
China (246)
Colorado (100)
Connecticut (89)
Delaware (61)
Europe (28458)
Florida (296)
Georgia (83)
Idaho (13)
Illinois (183)
India (6)
Indiana (92)
Iowa (9)
Japan (108)
Kansas (19)
Kentucky (6)
Louisiana (7)
Maine (16)
Maryland (266)
Massachusetts (1579)
Michigan (52)
Minnesota (110)
Mississippi (4)
Missouri (37)
Montana (6)
Nebraska (5)
Nevada (20)
New Hampshire (12)
New Jersey (642)
New Mexico (8)
New York (661)
North Carolina (366)
North Dakota (3)
Northern California (1224)
Ohio (100)
Oklahoma (8)
Oregon (9)
Pennsylvania (450)
Puerto Rico (4)
Rhode Island (15)
South America (292)
South Carolina (11)
Southern California (864)
Tennessee (46)
Texas (388)
United States (8260)
Utah (71)
Virginia (56)
Washington D.C. (19)
Washington State (202)
West Virginia (2)
Wisconsin (26)
175,503 Results for "mcgill university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
October 31, 2025
·
4 min read
Press Releases
Brain Cancer Canada Grants McGill University $100,000 to Advance Pediatric Brain Cancer Research
May 12, 2025
·
3 min read
Press Releases
QIAGEN collaborates with McGill University to advance microbiome research
November 13, 2024
·
8 min read
Biotech Bay
Bigfoot Biomedical Acquires Reinforcement Learning Algorithm for Insulin Titration Developed at McGill University
Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning algorithm for the titration of insulin settings developed at McGill University.
March 30, 2023
·
4 min read
Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce it has received a $250,000 Letter of Commitment for funding from the McGill University Health Centre (MUHC) Foundation.
January 19, 2023
·
8 min read
Business
InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01
Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF), an autologous stem cell therapy company, has received a $250,000 Letter of Commitment for funding from the McGill University Health Centre (MUHC) Foundation.
January 23, 2023
·
5 min read
Business
Fuzionaire to Collaborate with McGill University to Advance Chemistry Platform for Incorporation of Silicon into Pharmaceuticals
Fuzionaire, Inc. today announced a collaborative research agreement with McGill University that will leverage the company’s proprietary alkali metal catalyst platform in creating novel heterocyclic, biologically active, silicon-containing scaffolds and new silicon-based drug candidates.
September 1, 2022
·
3 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
1 of 17,551
Next
